FindTrial
Sign In

The Use of a Bi-Component (Carboxy Cellulose-Polysaccharide B) on the Knee Right After Ligament Reconstruction

The Use of Bi - Component Carboxymethylcellulose-Polysaccharide B in the Knee Joint After Anterior Cruciate Ligament Reconstruction - POL-CARB: polysaccharide-carboxymethylcellulose

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7k4yks
Enrollment
Unknown
Registered
2020-07-20
Start date
2019-11-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sprain and distention involving the cruciate ligament (anterior)

Interventions

Two groups will be compared, 15 patients without intervention and 15 patients with medication intra-articular carboxymethylcellulose-polysaccharide B after anterior cruciate ligament reconstruction (W
Drug
E04.555.110.026

Sponsors

Unifesp/EPM
Lead Sponsor
Unifesp/EPM
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients between 18 and 45 years old; isolated anterior cruciate ligament injury

Exclusion criteria

Exclusion criteria: Patients with active infectious processes; autoimmune or systemic diseases; previous surgery on the injured knee

Design outcomes

Primary

MeasureTime frame
Assess the patient's pain using the visual analogue pain scale method on the first, third, fifth and seventh postoperative day;Assess hemarthrosis on the first and seventh postoperative days using a scale from 0 to 4, with 0 - without edema, 1 - presence of fluids 2 - slight lifting of the patella 3 - balloon-shaped patella or tense effusion 4- inability to compress the patella against the femoral groove—

Secondary

MeasureTime frame
Evaluate the range of motion of the knee on the first and seventh postoperative day using a goniometer—

Countries

Brazil

Contacts

Public ContactRenan;Renan Chaim;Chaim

Unifesp/EPM;Unifesp/EPM

renanmchaim@yahoo.com.br;renanmchaim@yahoo.com.br55-11-986254999;+55-11-986254999

Outcome results

None listed

Source: REBEC (via WHO ICTRP)